Publicaciones en las que colabora con Juan Suárez Pérez (54)

2024

  1. Inhibition of Adult Neurogenesis in Male Mice after Repeated Exposure to Paracetamol Overdose

    International Journal of Molecular Sciences, Vol. 25, Núm. 4

  2. Plasma Concentrations of High Mobility Group Box 1 Proteins and Soluble Receptors for Advanced Glycation End-Products Are Relevant Biomarkers of Cognitive Impairment in Alcohol Use Disorder: A Pilot Study

    Toxics, Vol. 12, Núm. 3

  3. Sex-based differences in growth-related IGF1 signaling in response to PAPP-A2 deficiency: comparative effects of rhGH, rhIGF1 and rhPAPP-A2 treatments

    Biology of Sex Differences, Vol. 15, Núm. 1

2023

  1. Acute intrahippocampal administration of melanin-concentrating hormone impairs memory consolidation and decreases the expression of MCHR-1 and TrkB receptors

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 123

  2. Antidepressant Medication Does Not Contribute to the Elevated Circulating Concentrations of Acylethanolamides Found in Substance Use Disorder Patients

    International Journal of Molecular Sciences, Vol. 24, Núm. 19

  3. Antipsychotic Medication Influences the Discriminative Value of Acylethanolamides as Biomarkers of Substance Use Disorder

    International journal of molecular sciences, Vol. 24, Núm. 11

  4. Plasma Concentrations of Neurofilament Light Chain Protein and Brain-Derived Neurotrophic Factor as Consistent Biomarkers of Cognitive Impairment in Alcohol Use Disorder

    International Journal of Molecular Sciences, Vol. 24, Núm. 2

  5. Sex-Dependent Altered Expression of Cannabinoid Signaling in Hippocampal Astrocytes of the Triple Transgenic Mouse Model of Alzheimer’s Disease: Implications for Controlling Astroglial Activity

    International Journal of Molecular Sciences, Vol. 24, Núm. 16

  6. The Effect of Fat Intake with Increased Omega-6-to-Omega-3 Polyunsaturated Fatty Acid Ratio in Animal Models of Early and Late Alzheimer’s Disease-like Pathogenesis

    International Journal of Molecular Sciences, Vol. 24, Núm. 23

2022

  1. Dietary administration of D-chiro-inositol attenuates sex-specific metabolic imbalances in the 5xFAD mouse model of Alzheimer's disease

    Biomedicine and Pharmacotherapy, Vol. 150

  2. Discovery of V-0219: A Small-Molecule Positive Allosteric Modulator of the Glucagon-Like Peptide-1 Receptor toward Oral Treatment for "diabesity"

    Journal of Medicinal Chemistry, Vol. 65, Núm. 7, pp. 5449-5461

  3. Endocrine and Metabolic Impact of Oral Ingestion of a Carob-Pod-Derived Natural-Syrup-Containing D-Pinitol: Potential Use as a Novel Sweetener in Diabetes

    Pharmaceutics, Vol. 14, Núm. 8

  4. Maternal hypercaloric diet affects factors involved in lipid metabolism and the endogenous cannabinoid systems in the hypothalamus of adult offspring: sex-specific response of astrocytes to palmitic acid and anandamide

    Nutritional Neuroscience, Vol. 25, Núm. 5, pp. 931-944

  5. Salivary ATP13A2 is a potential marker of therapy-induced motor complications and is expressed by inclusions in submandibulary glands in Parkinson ́s disease

    Clinical Parkinsonism and Related Disorders, Vol. 7

  6. Sex Differences in Plasma Lysophosphatidic Acid Species in Patients with Alcohol and Cocaine Use Disorders

    Brain Sciences, Vol. 12, Núm. 5

  7. Trends in Psychiatric Hospitalizations of Patients With Dual Diagnosis in Spain

    Journal of Dual Diagnosis, Vol. 18, Núm. 2, pp. 92-100

  8. Vascular Endothelial Growth Factor as a Potential Biomarker of Neuroinflammation and Frontal Cognitive Impairment in Patients with Alcohol Use Disorder

    Biomedicines, Vol. 10, Núm. 5

  9. d-Pinitol promotes tau dephosphorylation through a cyclin-dependent kinase 5 regulation mechanism: A new potential approach for tauopathies?

    British Journal of Pharmacology, Vol. 179, Núm. 19, pp. 4655-4672

2021

  1. A combination of circulating chemokines as biomarkers of obesity-induced insulin resistance at puberty

    Pediatric Obesity, Vol. 16, Núm. 2

  2. A negative energy balance is associated with metabolic dysfunctions in the hypothalamus of a humanized preclinical model of alzheimer’s disease, the 5xfad mouse

    International Journal of Molecular Sciences, Vol. 22, Núm. 10